|
UBE2D1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.794300E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.853200E-01 |
| Normal-vs-Stage2 |
1.131200E-01 |
| Normal-vs-Stage3 |
5.429800E-02 |
| Normal-vs-Stage4 |
9.531600E-02 |
| Stage1-vs-Stage2 |
2.134000E-01 |
| Stage1-vs-Stage3 |
7.031500E-02 |
| Stage1-vs-Stage4 |
1.888370E-01 |
| Stage2-vs-Stage3 |
7.781800E-01 |
| Stage2-vs-Stage4 |
7.557200E-01 |
| Stage3-vs-Stage4 |
9.586200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.446400E-01 |
| Normal-vs-AfricanAmerican |
4.888300E-02 |
| Normal-vs-Asian |
8.441800E-02 |
| Caucasian-vs-AfricanAmerican |
1.842570E-01 |
| Caucasian-vs-Asian |
9.538700E-03 |
| AfricanAmerican-vs-Asian |
1.148240E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.729800E-01 |
| Normal-vs-Female |
2.643600E-04 |
| Male-vs-Female |
4.230600E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.867000E-01 |
| Normal-vs-Extreme_Weight |
6.223000E-01 |
| Normal-vs-Obese |
7.769700E-02 |
| Normal-vs-Extreme_Obese |
6.648600E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.922400E-01 |
| Normal_Weight-vs-Obese |
5.269000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.717000E-01 |
| Extreme_Weight-vs-Obese |
1.562230E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.516000E-01 |
| Obese-vs-Extreme_Obese |
2.713400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.683800E-03 |
| Normal-vs-Age(41-60Yrs) |
4.556000E-02 |
| Normal-vs-Age(61-80Yrs) |
3.361000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.696600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.444200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.403520E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.918900E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.132600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.188500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.330000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.528620E-01 |
| Normal-VS-Type2 PRCC |
8.901200E-01 |
| Normal-VS-KIRP CIMP |
2.323100E-03 |
| Normal-VS-Unclassified PRCC |
9.106300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.558400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.804400E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
3.817200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.4612000005273E-07 |
| Type2 PRCC-VS-Unclassified PRCC |
1.523040E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.59719999999997E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.403000E-01 |
| Normal-vs-N1 |
3.098800E-03 |
| Normal-vs-N2 |
6.981600E-01 |
| N0-vs-N1 |
2.037500E-03 |
| N0-vs-N2 |
6.718200E-01 |
| N1-vs-N2 |
3.549800E-01 |
|
|
